Author

Amanda M. Valdiosera

Observed name: Amanda Valdiosera

Institution: Sana Biotechnology (United States)

Observed institutions: AbbVie (United States), Sana Biotechnology (United States)

OpenAlex ID: A5077242511

Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs

2015 · Christopher R. Behrens, Edward H. Ha, et al. · Molecular Pharmaceutics · 163

Uncialamycin-based antibody–drug conjugates: Unique enediyne ADCs exhibiting bystander killing effect

2021 · K. C. Nicolaou, Stephan Rigol, et al. · Proceedings of the National Academy of Sciences · 42

Evaluation of PNU-159682 antibody drug conjugates (ADCs)

2020 · Dane Holte, Joseph P. Lyssikatos, et al. · Bioorganic & Medicinal Chemistry Letters · 26

Synthesis and Biological Evaluation of Shishijimicin A-Type Linker-Drugs and Antibody–Drug Conjugates

2020 · K. C. Nicolaou, Ruofan Li, et al. · Journal of the American Chemical Society · 17

Design, Synthesis, and Biological Evaluation of Tubulysin Analogues, Linker-Drugs, and Antibody–Drug Conjugates, Insights into Structure–Activity Relationships, and Tubulysin–Tubulin Binding Derived from X-ray Crystallographic Analysis

2021 · K. C. Nicolaou, Saiyong Pan, et al. · The Journal of Organic Chemistry · 13

Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b

2022 · Christina Chaivorapol, Pascal Beauchesne, et al. · Blood · 2

Works count: 6

Citation count: 263

H-index: 5

I10-index: 5